Patients @ years of age or older with CAD and baseline systolic BP > @ mm Hg randomized to a treatment strategy on the basis of either atenolol/hydrochlorothiazide or verapamil-SR ( sustained release ) / trandolapril in INVEST ( INternational VErapamil SR Trandolapril STudy ) were categorized into @ groups on the basis of achieved on-treatment systolic BP : group @ , < @ mm Hg ; group @ , @ to < @ mm Hg ; and group @,@ mm Hg .